Serial Number
98978211
Owner
Neurocrine Biosciences, Inc.Attorney
Allison Strickland RickettsFirst Use Date
Apr 24, 2024
Filing Date
Feb 26, 2024
WHAT THE C@H?! Trademark
Serial Number: 98978211 • Registration: 8307461
Trademark Classes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
6027 Edgewood Bend Court
San Diego, CA 92130
Entity Type: 03
Legal Representation
Correspondence Address
Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.
151 West 42nd St., 17th Fl.
New York, NY 10036
United States
Trademark Details
Filing Date
February 26, 2024
Registration Date
June 16, 2026
First Use Anywhere
April 24, 2024
First Use in Commerce
April 24, 2024
Published for Opposition
April 8, 2025
Goods & Services
Providing medical information; providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of endocrine diseases and disorders
Providing information about medical research; providing medical research information in the field of congenital adrenal hyperplasia; providing medical research information in the field of endocrine diseases and disorders
Promoting awareness of congenital adrenal hyperplasia; Promoting awareness of endocrine diseases and disorders; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy
